Ind-swift Ltd. is a pleased to introduce Ind-Swift Ltd, public listed company in Indian Stock market as one of the fastest growing pharmaceutical company of India. Ind-Swift is committed to build long lasting associations through the strategic selection of products, partners and markets. Today Ind-Swifts market reach spans over 70 countries across five continents as it serves discerning customers in Africa, Australia, Asia, Europe, Latin America & Central America, the middle east & CIS.Ind-Swift Ltd. established in year 1984, Ind-Swift is one of the leading Indian manufacturer and exporter of APIs and Formulations. Kindly visit our website www.gbu.indswift.com. The turnover of Ind-Swift conglomerate expected to reach USD 475 million in financial year 2014-2015. Ind-Swift group is engaged in manufacturing, marketing and exports of APIs and Finished Formulations.Please note that our plant is approved by MHRA UK, TGA Australia, ANVISA Brazil, GCC Saudi Arabia, MOH Dubai and other African countries.